• Activity INFORMATION

  Overview

  Opioid therapy is indicated for acute pain and cancer-related pain; however, it is also often used in chronic non-cancer pain management once non-pharmacologic and non-opioid therapies have failed. When opioid therapy is warranted, careful consideration should be given when selecting the most appropriate agent. This issue focuses on similarities and differences among opioid medications, along with common adverse effects, monitoring parameters, and risk mitigation strategies that pharmacists can provide to improve safety. Federal and Florida pharmacy practice laws are discussed in relation to prescribing and dispensing controlled substances, determining the validity and therapeutic appropriateness of controlled substance prescriptions, and the use of risk mitigation techniques to assure the safe use of opioid therapy.

  This course has been approved by the Florida Board of Pharmacy to meet the requirement of 2.0 hours of continuing education on the topic of validation of prescriptions for controlled substances for Florida pharmacists.

  
  

  Handouts

  • Homestudy PDF :   22285H08.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify patients who would benefit most from co-prescribed naloxone and the laws regarding prescribing, dispensing, and standing orders in Florida

  Recall instructions for patient storage and disposal of controlled substances

  Recognize key counseling points when dispensing controlled substance prescriptions for opioids

  Recognize the importance of drug utilization review for controlled substances and how to address any problems identified such as drug-drug interactions, side effects, or problems with doses

  Identify Florida pharmacy practice laws regarding the prescribing and dispensing of controlled substances

  Recall available risk screening and mitigation tools for opioid therapy

  Recognize similarities and differences among opioid medications

  Describe how to assess controlled substance prescriptions for legitimate medical purpose and therapeutic appropriateness/value to ensure access to controlled substances for patients with a valid prescription

  Identify appropriate resources for treatment for opioid dependence, addiction, misuse, or abuse

  Describe how to best utilize a prescription drug monitoring program database

  List common red flags of controlled substance drug diversion and how to ensure patients have access to controlled substances

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-962804

  Universal Activity Number

  Pharmacist 0798-0000-22-285-H08-P
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Hanna  Hollingsworth, PharmD, BCPS Clinical Pharmacy Specialist, Parkland Health

  Amanda  Mullins, PharmD, BCPS Clinical Pharmacy Specialist, Pain Management, VA St. Louis Healthcare System

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).